Kronos Bio, Inc. (KRON) Misses Q1 EPS by 2c

Kronos Bio, Inc. (NASDAQ: KRON) reported Q1 EPS of ($0.46), $0.02 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $1.22 million versus the consensus estimate of $5 million.

For earnings history and earnings-related data on Kronos Bio, Inc. (KRON) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c